The first stop for professional medicines advice

Primary Care and PCNs, Guidance

44 results

Applied filters

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Direction (PGDs) for in End of Life Care

Avoid prescribing desiccated (natural) thyroid extract

20 January 2022Levothyroxine is the standard of care for treating hypothyroidism. Desiccated or natural thyroid extracts (DTE) are not routinely recommended.

Using coenzyme Q10 supplements for statin-induced muscle symptoms

18 February 2022People often buy coenzyme Q10 supplements to help with statin-induced muscle symptoms. However, there is insufficient evidence to recommend its use.

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Switching doxazosin XL tablets to doxazosin standard tablets

12 May 2022Doxazosin XL tablets should not routinely be prescribed. Guidance is provided on switching doxazosin XL tablets to standard release tablets.

Maintaining the vaccine cold chain in primary care

17 December 2020A sample policy for maintaining the vaccine cold chain in primary care for local adaptation and adoption.

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

Patient Group Direction use in Primary Care Networks

8 January 2020Guidance on the legislation and governance required when considering the use of PGDs across a PCN

Doctors, dentists, and use of PGDs

15 December 2020Doctors and dentists cannot supply or administer medications under a PGD or Written Instruction.  This page gives further detail on why this is the case.

Choosing an antidepressant for people with coronary heart disease

2 July 2021Making a suitable choice of antidepressant in CHD needs to include considerations of both the patient and the characteristics of the medicines.